Latest news and articles about Pfizer from NEX English
BioNTech, the German company known for developing one of the first mRNA COVID vaccines, announced a complete halt to its vaccine production, endangering approximately 1860 jobs. This decision is part of a restructuring effort to focus on research and treatment of other diseases.
Pfizer has announced the development of an innovative treatment for alopecia areata, an autoimmune condition that causes sudden hair loss. This new therapy represents a significant step in addressing a condition that affects many individuals worldwide.
Pfizer and BioNTech have announced the suspension of their COVID-19 vaccine study in the United States due to difficulties in recruiting participants. This decision comes at a critical time as countries strive to enhance vaccination campaigns against emerging variants.
A Belgian court has mandated Poland and Romania to acquire Pfizer's COVID-19 vaccines worth up to <strong>$2.2 billion</strong>. This ruling stems from the countries' obligations under previous agreements with the company.
A Belgian court has ruled that Poland and Romania must pay <strong>€1.9 billion</strong> (approximately <strong>$2.2 billion</strong>) to American pharmaceutical company Pfizer due to their refusal to accept COVID-19 vaccines during the pandemic. This ruling marks a significant victory for Pfizer in its efforts to enforce contractual agreements.
Pfizer, in collaboration with French partner Valneva, announced its intention to seek regulatory approval for a Lyme disease vaccine after successful advanced clinical trials. This initiative comes amid growing interest in new methods to combat this globally significant health threat.